REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...

Thirty minutes was all that former President Joe Biden’s top health officials had allotted to discuss a policy that would ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

Campylobacter infections are the most common foodborne illnesses in the U.S., sickening an estimated 1.5 million people each ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

The European Union on Wednesday outlined that steps that Apple must take to open up its iPhone and iPad operating systems to ...

SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...

Velico is pleased to announce that Our Blood Institute (OBI), the nation's sixth-largest independent blood center, will ...

Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...